LHX
L3Harris Technologies, Inc.
LHX has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over LHX overall, supported by stronger valuation and stronger modeled upside.
LHX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
LHX's revenue, profitability, cash flow and balance sheet are all currently healthy.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
LHX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $272 | — |
| Current | 25x | $272 | — |
| Cheap | 26x | $275 | +1.2% |
| Fair | 31x | $334 | +23% |
| Expensive | 38x | $403 | +48% |
Historical ranges are pointers, not guarantees.
LHX's PE is in its cheap range at 25x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over LHX in the historical PE scenario, which offers more potential upside but is not a forecast.
LHX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LHX, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
LHX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.93 | +21% |
| Q3 2026 | $10.72 | +15% |
| Q2 2026 | $9.90 | +11% |
| Q1 2026 | $9.21 | +9.3% |
| Q4 2025 | $8.53 | +8.4% |
| Q3 2025 | $9.31 | +47% |
| Q2 2025 | $8.95 | +43% |
| Q1 2025 | $8.43 | +37% |
| Q4 2024 | $7.87 | +22% |
LHX's earnings per share have climbed steadily: $10.72 over the past year, up 15% from the year before, and higher year over year for eight quarters in a row.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over LHX on earnings, with stronger typical year-over-year growth.
LHX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +7.1% |
| Q2 2026 | $5.9B | +8.4% |
| Q1 2026 | $5.7B | +12% |
| Q4 2025 | $21.9B | +296% |
| Q3 2025 | $5.7B | +6.9% |
| Q2 2025 | $5.4B | +2.4% |
| Q1 2025 | $5.1B | -1.5% |
| Q4 2024 | $5.5B | +3.4% |
LHX's revenue has grown year over year for six quarters in a row: $6.1B last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +2 points |
| Q2 2026 | 11% | +0.6 points |
| Q1 2026 | 11% | +1.1 points |
| Q4 2025 | 9.7% | -0.7 points |
| Q3 2025 | 11% | +1.6 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 10% | +3 points |
| Q4 2024 | 10% | +8.9 points |
LHX's operating margin was 13% last quarter, up 2 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over LHX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over LHX on profitability, with a higher operating margin.
LHX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +195% |
| Q2 2026 | $771M | +40% |
| Q1 2026 | -$194M | -$93M |
| Q4 2025 | $1.8B | +78% |
| Q3 2025 | $427M | -39% |
| Q2 2025 | $552M | -16% |
| Q1 2025 | -$101M | +$118M |
| Q4 2024 | $1B | +55% |
LHX generated $3.6B in free cash flow over the past year, up 93% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over LHX on cash flow, with more consistent year-over-year improvement.
LHX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -400K shares |
| 1 year | -0.6% | -1.2M shares |
| 3 years | -1.7% | -3.2M shares |
| 5 years | -7.3% | -14.7M shares |
| Available history | -16% | -35.2M shares |
LHX has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $73M |
| Q2 2026 | $229M |
| Q1 2026 | $296M |
| Q4 2025 | $156M |
| Q3 2025 | $176M |
| Q2 2025 | $253M |
| Q1 2025 | $569M |
| Q4 2024 | $42M |
LHX spent $754M buying back its own shares over the past year, down 28% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
LHX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 3.3x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | 3.6x | Elevated |
LHX's net debt is about 1.6 years of its operating earnings (EBITDA), down from 3.3 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over LHX on leverage, with a lower net debt burden relative to earnings.
LHX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.1 | Neutral |
| Stochastic | 55.9 | Neutral |
LHX's weekly RSI is 49 (neutral) and its Stochastic is 56 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
LHX PE vs Industrials Sector
| Metric | LHX | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 24x | 5.4% above |
| PE % | 15 | 58 | 43 pts below |
LHX has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
LHX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $252.9 | 7.5% above |
| 20 week MA | $266.6 | 2% above |
| 50 week MA | $302.5 | 10% below |
| 100 week MA | $274.3 | 0.9% below |
| 200 week MA | $241.3 | 13% above |
LHX has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
LHX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $201.7 | $185.2 | -8.2% |
| 2021 | $185.2 | $208.3 | +12% |
| 2022 | $208.3 | $206.2 | -1% |
| 2023 | $206.2 | $210.6 | +2.1% |
| 2024 | $210.6 | $212.4 | +0.8% |
| 2025 | $212.4 | $296.8 | +40% |
| 2026 YTD | $296.8 | $271.8 | -8.4% |
LHX has finished higher in four of the last six years. It's down 8.4% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over LHX on returns for 2026, with the stronger performance.